Live Breaking News & Updates on Zentalis Pharmaceuticals Company Profile

Stay updated with breaking news from Zentalis pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9.48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […] ....

Diana-hausman , Stifel-nicolaus , Zentalis-pharmaceuticals-inc , News-ratings-for-zentalis-pharmaceuticals-daily , Zentalis-pharmaceuticals-company-profile , Nasdaq , Decheng-capital , Vanguard-group-inc , Pricet-rowe-associates-inc , Zentalis-pharmaceuticals-stock-down , Institutional-trading-of-zentalis-pharmaceuticals , Hermes-inc

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9.48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […] ....

Diana-hausman , Stifel-nicolaus , Zentalis-pharmaceuticals-stock-down , Zentalis-pharmaceuticals-inc , Vanguard-group-inc , Pricet-rowe-associates-inc , Decheng-capital , Nasdaq , Zentalis-pharmaceuticals , Eventide-asset-management , Zentalis-pharmaceuticals-company-profile , Hermes-inc

Insider Selling: Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) CFO Sells 9,597 Shares of Stock

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) CFO Cam Gallagher sold 9,597 shares of the business’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $11.98, for a total transaction of $114,972.06. Following the transaction, the chief financial officer now owns 633,680 shares in the company, […] ....

Stifel-nicolaus , Nasdaq , Zentalis-pharmaceuticals-inc , Zentalis-pharmaceuticals-stock-performance , Vanguard-group-inc , Tower-research-capital , Sg-americas-securities , Quarter-for-zentalis-pharmaceuticals , Zentalis-pharmaceuticals-company-profile , Charles-schwab-investment-management-inc , York-mellon-corp , News-ratings-for-zentalis-pharmaceuticals-daily

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Consensus Rating of "Moderate Buy" from Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price target among […] ....

China , Diana-hausman , Stifel-nicolaus , Td-asset-management-inc , Zentalis-pharmaceuticals-company-profile , Analyst-recommendations-for-zentalis-pharmaceuticals , China-universal-asset-management-co , York-mellon-corp , Securities-exchange-commission , News-ratings-for-zentalis-pharmaceuticals-daily , Zentalis-pharmaceuticals , Institutional-trading-of-zentalis-pharmaceuticals

HC Wainwright Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $40.00

HC Wainwright Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $40.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Wellington , New-zealand-general , New-zealand , Stifel-nicolaus , Melissab-epperly , Diana-hausman , Zentalis-pharmaceuticals-company-profile , Eventide-asset-management , Decheng-capital , Zentalis-pharmaceuticals , News-ratings-for-zentalis-pharmaceuticals-daily , Zentalis-pharmaceuticals-stock-performance